Hi Tech Pharmacal Co Inc Watch

from 8-K 2 pages Reference Is Made to That Certain Letter Agreement, Dated October 18, 2011, by and Between Hi-Tech Pharmacal Co., Inc. (The “Company”) and You in Connection With Your Employment (The “Letter Agreement”). All Terms Not Defined Herein Shall Have the Meanings Ascribed to Them in the Letter Agreement. 1. the Letter Agreement Is Hereby Amended as Follows

from 8-K 3 pages Amendment No. 1 to Employment Agreement

from 8-K 3 pages Amendment No. 4 to Employment Agreement

from 8-K 9 pages October 18, 2011 Mr. Gary April October 18, 2011 Page 2

from 8-K 2 pages Amendment No. 3 to Employment Agreement

from 8-K 12 pages Employment Agreement, Effective as of November 10, 2010 (“Effective Date”), by and Between Hi-Tech Pharmacal Co., Inc., a Delaware Corporation With Offices at 369 Bayview Avenue, Amityville, New York 11701 (The “Corporation”), and Reuben Seltzer, an Individual Residing at 21 Glenwood Drive, Great Neck, New York 11021 (The “Executive”)

from 10-K 10 pages Supply Agreement for Dorzolamide Hydrochloride

from 8-K 7 pages In Addition to Your Annual Salary, You Will Receive a Bonus During Each Year of Your Employment Equal to 2% of the Increase in Net Sales of the Hcp Division Over the Immediately Preceding Year’s Net Sales of the Hcp Division (The “Bonus”). for Purposes of This Letter, the Parties Agree That (I) Domestic Sales for the Period May 1, 2007 to April 30, 2008 (“Fiscal 2008”) Shall Be Deemed to Be $10,846,000. for Purposes of This Letter, “Net Sales” Shall Mean Gross Sales Net of Any Deductions, Returns, Discounts, Allowances, Chargebacks and Rebates, as Conclusively Determined by the Company’s Chief Executive Officer or Chief Financial Officer, Which Determination Shall Be Final and Binding Upon You and the Company

from 8-K 3 pages Amendment No. 1 to Employment Agreement

from 8-K 11 pages Section 3. Term of Employment. the Term of This Contract Shall Commence as of December 27, 2007 (The “Effective Date”) and Shall Continue Until December 26, 2009 Unless Earlier Terminated by Employee Upon 30 Days Advance Written Notice to the Corporation, or Unless Earlier Terminated Pursuant to the Provisions of Section 5 Hereof (The “Term”). Section 4. Compensation of Employee

from 8-K 3 pages Amendment No. 2 to Employment Agreement

from 8-K/A 15 pages Employment Agreement, as of February 27, 2009, by and Between Hi-Tech Pharmacal Co., Inc., a Delaware Corporation With Offices at 369 Bayview Avenue, Amityville, New York 11701 (The “Corporation”), and Davis S. Caskey, an Individual Residing at 408 Welwyn Road, Richmond, Virginia 23229 (“Employee”)

from 8-K/A 42 pages Asset Purchase Agreement

from 10-Q 42 pages Asset Purchase Agreement

from 10-Q 12 pages Section 4. Compensation of Executive

from 10-K 1 page Amendment No. 1 to the Amended and Restated Executive Employment Agreement

from 10-K 15 pages Section 4. Compensation of Employee

from 10-Q 11 pages Section 4. Compensation of Executive

from 8-K 42 pages Securities Purchase Agreement

from 10-Q ~5 pages Employment Agreement of Arthur S Goldberg